Srikant Viswanadha,Swaroop Kumar Kumar Venkata Sat Vekalanka
申请号：
US16759629
公开号：
US20200281918A1
申请日:
2018.10.29
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to the use of a calcium release-activated calcium (CRAC) channel modulator, such as N-[4-(3,5-dicyclopropyl-1H-pyrazol-1-yl)phenyl]-2-(quinolin-6-yl)acetamide (Compound (A)) or a pharmaceutically acceptable salt thereof, or a pharmaceutical composition containing such a CRAC channel modulator for the treatment of haematological and solid cancers.
